Total Payments
$9,671
2024 Payments
$112.48
Companies
42
Transactions
539
Medicare Patients
1,777
Medicare Billing
$281,310
Payment Breakdown by Category
Food & Beverage$9,638 (99.7%)
Travel$25.25 (0.3%)
Education$7.29 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,638 | 537 | 99.7% |
| Travel and Lodging | $25.25 | 1 | 0.3% |
| Education | $7.29 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,850 | 138 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,346 | 88 | $0 (2021) |
| Janssen Biotech, Inc. | $638.63 | 59 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $487.54 | 39 | $0 (2021) |
| UCB, Inc. | $404.10 | 23 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $385.49 | 15 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $330.53 | 3 | $0 (2024) |
| PFIZER INC. | $315.99 | 26 | $0 (2021) |
| Allergan Inc. | $309.78 | 14 | $0 (2019) |
| Amarin Pharma Inc. | $250.28 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.48 | 2 | AstraZeneca Pharmaceuticals LP ($91.53) |
| 2022 | $155.65 | 4 | ABBVIE INC. ($131.77) |
| 2021 | $986.86 | 53 | AbbVie Inc. ($614.49) |
| 2020 | $1,113 | 55 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($214.07) |
| 2019 | $3,188 | 173 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($847.83) |
| 2018 | $2,091 | 130 | AbbVie, Inc. ($354.44) |
| 2017 | $2,023 | 122 | AbbVie, Inc. ($303.87) |
All Payment Transactions
539 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $91.53 | General |
| Category: Respiratory | ||||||
| 12/09/2022 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2022 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $106.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $25.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $84.89 | General |
| Category: Cardio-renal | ||||||
| 11/11/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/08/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.67 | General |
| Category: GI | ||||||
| 10/28/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Gastroenterology | ||||||
| 09/03/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/01/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/25/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2021 | Medtronic, Inc. | GI Genius (Device) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Gastrointestinal AI | ||||||
| 08/20/2021 | Medtronic, Inc. | GI Genius (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastrointestinal AI | ||||||
| 08/18/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Gastroenterology | ||||||
| 08/05/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/02/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 791 | 994 | $440,097 | $143,277 |
| 2020 | 12 | 986 | 1,177 | $436,012 | $138,032 |
Total Patients
1,777
Total Services
2,171
Medicare Billing
$281,310
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 274 | 462 | $101,640 | $69,451 | 68.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 122 | 123 | $128,535 | $26,890 | 20.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 149 | 150 | $83,220 | $15,513 | 18.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 47 | 47 | $29,751 | $9,192 | 30.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 92 | 96 | $66,060 | $8,651 | 13.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 66 | $10,560 | $5,559 | 52.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $7,290 | $4,737 | 65.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 12 | 12 | $7,596 | $2,430 | 32.0% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 11 | $5,445 | $855.20 | 15.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 243 | 337 | $73,460 | $37,852 | 51.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 113 | 113 | $117,452 | $25,474 | 21.7% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 145 | 145 | $75,805 | $13,660 | 18.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 75 | 76 | $22,040 | $13,330 | 60.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 115 | 137 | $21,920 | $12,153 | 55.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 106 | 110 | $64,400 | $9,311 | 14.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 64 | 133 | $14,630 | $8,325 | 56.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 40 | 40 | $25,320 | $8,063 | 31.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 38 | 38 | $10,260 | $6,199 | 60.4% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 14 | 15 | $7,425 | $1,535 | 20.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 17 | $1,620 | $1,095 | 67.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 16 | $1,680 | $1,037 | 61.7% |
About Dr. Robert Atkins, M.D
Dr. Robert Atkins, M.D is a Gastroenterology healthcare provider based in Bryn Mawr, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023049400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Atkins, M.D has received a total of $9,671 in payments from pharmaceutical and medical device companies, with $112.48 received in 2024. These payments were reported across 539 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,638).
As a Medicare-enrolled provider, Atkins has provided services to 1,777 Medicare beneficiaries, totaling 2,171 services with total Medicare billing of $281,310. Data is available for 2 years (2020–2021), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bryn Mawr, PA
- Active Since 07/05/2006
- Last Updated 04/05/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1023049400
Products in Payments
- STELARA (Biological) $820.27
- Humira (Biological) $749.52
- HUMIRA (Biological) $675.63
- XIFAXAN (Drug) $585.34
- APRISO (Drug) $432.64
- Cimzia (Drug) $404.10
- Entyvio (Biological) $286.50
- Vascepa (Drug) $250.28
- DIFICID (Drug) $247.26
- Trulance (Drug) $245.71
- XELJANZ (Drug) $191.86
- LINZESS (Drug) $181.42
- VIBERZI (Drug) $156.96
- Sucraid (Drug) $151.31
- UBRELVY (Drug) $131.77
- TRULANCE (Drug) $131.27
- FARXIGA (Drug) $125.00
- NUZYRA (Drug) $122.90
- Repatha (Biological) $120.80
- Creon (Drug) $120.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bryn Mawr
Dr. Jeffrey Retig, M.d, M.D
Gastroenterology — Payments: $33,093
Gastroenterology $33,093
Dr. Thomas Mckenna, M.d, M.D
Gastroenterology — Payments: $18,197
Gastroenterology $18,197
Toan Nguyen, M.d, M.D
Gastroenterology — Payments: $11,530
Gastroenterology $11,530
Robert Levitt, M.d, M.D
Gastroenterology — Payments: $5,798
Gastroenterology $5,798
Dr. Nikhita Dharbhamulla, M.d, M.D
Gastroenterology — Payments: $4,634
Gastroenterology $4,634
Jack Collazzo, M.d, M.D
Gastroenterology — Payments: $4,267
Gastroenterology $4,267